Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma

Journal:
Science Advances
Published:
Affiliations:
6
Authors:
9
Institutions Authors Share
Johns Hopkins Medicine (JHM), JHU, United States of America (USA)
6.750000
0.75
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)
2.250000
0.25